This Post Was Syndicated Under License Via QuoteMedia
Dynamic plant-based food and beverage company Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced receipt of a Health Canada cultivation license for Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its portfolio company, Spot Therapeutics Inc., for its Fredericton-based production and distribution facility. Per the update, the newly licensed facility will operate under the flagship Tweed banner, and the cultivation license initiates a long-term (25-year) cash flow stream anticipated to be approximately $2.85 million per year with commencement expected to begin in September 2019. “The long-term income stream from Spot, ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.